Clinical Trials Directory

Trials / Completed

CompletedNCT00168402

A Study Using Botulinum Toxin Type A in Patients With Axillary Hyperhidrosis

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
193 (actual)
Sponsor
Allergan · Industry
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

This is a three-year study in subjects with axillary hyperhidrosis involving injection of Botulinum Toxin Type A into the axilla to reduce sweating.

Conditions

Interventions

TypeNameDescription
DRUGBotulinum Toxin Type A

Timeline

Start date
2002-02-01
Primary completion
2005-10-01
Completion
2005-10-01
First posted
2005-09-15
Last updated
2011-05-30

Source: ClinicalTrials.gov record NCT00168402. Inclusion in this directory is not an endorsement.

A Study Using Botulinum Toxin Type A in Patients With Axillary Hyperhidrosis (NCT00168402) · Clinical Trials Directory